Beyond the test result
Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’ serious and complex medical challenges.
These are the stories of the people throughout that journey — from the laboratorians conducting tests and delivering results, to the physicians guiding diagnosis and treatment, to the patients who need answers worldwide.
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
Top highlights include: Additional insight for when the vaccine will be available for children, Mayo Clinic aims to offer more walk-in COVID-19 vaccine clinics in Rochester, and how preventive screening leads to an early diagnosis of treatable breast cancer.
As an experienced laboratory professional, Peter Wegwerth was well-suited to pivot from his work in Mayo Clinic's Biochemical Genetics Laboratory to redeployment in a COVID-19 testing lab when the pandemic hit in 2020.
This week’s research roundup features a study on positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing.
Top highlights include: New CDC guidance for vaccinated adults, the importance of the second dose, and who's at higher risk for serious symptoms.
The Office of Decedent Affairs plays a key role in Mayo Clinic’s mission as its staff guide families through the logistics and complexities of a loved one’s death with skill and empathy.
This week’s research roundup features a study on how the CLL-international prognostic index (CLL-IPI) predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Top highlights include: J&J COVID-19 vaccine pause ends, combating allergies during the pandemic, and researchers question effectiveness of mRNA COVID-19 vaccines for solid organ transplant patients.
Kae Essler’s behind-the-scenes role managing Mayo Clinic Laboratories’ Client Conversion team may not be highly visible, but her group’s work is crucial to ensuring an easy transition for clients and setting the stage for a productive collaboration going forward.
This week’s research roundup features a study on protocadherin 7-associated membranous nephropathy.
Top highlights include: Mayo Clinic's response to the Johnson & Johnson COVID-19 vaccine pause, sexually transmitted infections, and should pregnant women be vaccinated for COVID-19?
Dr. Dollahite received world-class cancer treatment from a web of health care organizations, including Mayo Clinic in Rochester, Minnesota. Yet she never left New York; most of her treatment occurred in Ithaca. What made that possible was Cayuga Medical Center’s collaborative relationship with Mayo Clinic. Genetic testing at Mayo Clinic Laboratories provided important information about Dr. Dollahite’s cancer.